IP Library Granted Patent US 8,658,395
Granted Patent B2
US 8,658,395 · App. 13/546,582 · Granted Feb 25, 2014

Selective incorporation of 5-hydroxytryptophan into proteins in mammalian cells

Inventors: Zhiwen Zhang (San Diego, CA); Lital Alfonta (San Diego, CA); Peter G. Schultz (La Jolla, CA)
Assignee: The Scripps Research Institute
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,658,395
App. No.
13/546,582
Granted
Feb 25, 2014
Kind
B2
Abstract

This invention provides methods and compositions for incorporation of an unnatural amino acid into a peptide using an orthogonal aminoacyl tRNA synthetase/tRNA pair. In particular, an orthogonal pair is provided to incorporate 5-hydroxy-L-tryptophan in a position encoded by an opal mutation.

Claims (14)

1. A method of reacting a peptide comprising a 5-hydroxy-L-tryptophan (5-HTPP) with a molecule reactive with 5-HTPP, the method comprising:

providing a peptide comprising one or more unnatural amino acids wherein at least one of the unnatural amino acids is 5-hydroxy-L-tryptophan (5-HTPP),

providing a reactive molecule reactive with the 5-HTPP; and,

reacting the reactive molecule covalently with the 5-HTPP, wherein said providing the peptide comprises:

i) preparing a construct comprising a nucleic acid sequence encoding an orthogonal tRNA synthetase (O-RS) and comprising at least 90% identity to the sequence of SEQ ID NO: 2, the O-RS comprising a proline residue at a position corresponding to position 144 of SEQ ID NO: 2, wherein the O-RS aminoacylates a reference orthogonal tRNA (O-tRNA) of SEQ ID NO: 3 with a 5-HTPP when the reference O-tRNA, 5-HTPP, and the O-RS are present in a eukaryotic cell;

ii) preparing a construct comprising a nucleic acid sequence encoding an O-tRNA comprising: at least 90% identity to SEQ ID NO: 3, wherein the O-tRNA is aminoacylated with a 5-HTPP by a reference O-RS of SEQ ID NO: 2 when the reference O-RS, 5-HTPP, and the O-tRNA are present in a eukaryotic cell;

iii) introducing the O-RS construct and the O-tRNA construct into the eukaryotic cell; and,

iv) preferentially aminoacylating an expressed O-tRNA with the 5-HTPP, wherein said aminoacylation is catalyzed by an expressed O-RS, wherein the O-tRNA recognizes a selector codon in a nucleic acid sequence encoding the peptide, whereby the 5-HTPP is incorporated into the peptide in the eukaryotic cell.

2. The method of claim 1 , further comprising applying a voltage to the peptide, thereby reacting the 5-HTPP with the reactive molecule.

3. The method of claim 1 , wherein reacting comprises cross-linking.

4. The method of claim 1 , wherein the reactive molecule comprises an unnatural amino acid in another peptide.

5. The method of claim 4 , wherein the amino acid on another peptide is selected from the group consisting of: 5-HTPP and cysteine.

6. The method of claim 1 , further comprising detecting an interaction between the peptide and another peptide.

7. The method of claim 6 , wherein said detecting comprises fluoroscopy.

Assignments (1)
CONFIRMATORY LICENSE Recorded Dec 21, 2017
From: SCRIPPS RESEARCH INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 044932/0840 →
Continuity (5)
Continuation 12798979 · Apr 14, 2010
Division 10580987
Provisional Application 60548761 · Feb 26, 2004
Provisional Application 60531312 · Dec 18, 2003
Related Publication 20120282626A1 · Nov 8, 2012